-+ 0.00%
-+ 0.00%
-+ 0.00%

Sarepta files Form 3 for CEO, director Michael Severino

PUBT·07/30/2026 00:00:46
Listen to the news
Sarepta files Form 3 for CEO, director Michael Severino
  • Sarepta Therapeutics CEO Michael Severino filed an initial Form 3 as a director and officer on July 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-324437), on July 29, 2026, and is solely responsible for the information contained therein.